Flt3-ligand-mobilized peripheral blood, but not Flt3-ligand-expanded bone marrow, facilitating cells promote establishment of chimerism and tolerance

Institute for Cellular Therapeutics, University of Louisville, 570 S. Preston Street, Suite 404, Louisville, Kentucky 40202-1760, USA.
Stem Cells (Impact Factor: 6.52). 05/2006; 24(4):936-48. DOI: 10.1634/stemcells.2005-0395
Source: PubMed


Facilitating cells (CD8+/TCR-) (FCs) enhance engraftment of limiting numbers of hematopoietic stem cells (HSCs). The primary component of FCs is precursor-plasmacytoid dendritic cells (p-preDCs), a tolerogenic cell expanded by Flt3-ligand (FL). In this study, we evaluated the function and composition of FL-expanded FCs. FL treatment resulted in a significant increase of FCs in bone marrow (BM) and peripheral blood (PB). When FL-expanded FCs were transplanted with c-Kit+/Sca-1+/Lin- (KSL) cells into allogeneic recipients, BM-FCs exhibited significantly impaired function whereas PB-FCs were potently functional. A significant upregulation of P-selectin expression and downregulation of VCAM-1 (vascular cell adhesion molecule 1) were present on FL-expanded PB-FCs compared with FL BM-FCs. Stromal cell-derived factor-1 (SDF-1), and CXCR4 transcripts were significantly increased in FL PB-FCs and decreased in FL BM-FCs. Supernatant from FL PB-FCs primed HSC migration to SDF-1, confirming production of the protein product. The FL PB-FCs contained a predominance of p-preDCs and natural killer (NK)-FCs, and NK-FCs were lacking in FL BM-FCs. The impaired function for BM-FCs was restored within 5 days after cessation of treatment. Taken together, these data suggest that FCs may enhance HSC homing and migration via the SDF-1/CXCR4 axis and adhesion molecule modulation. These findings may have implications in development of strategies for retaining function of ex vivo manipulated FCs and HSCs.

2 Reads
  • Source

  • [Show abstract] [Hide abstract]
    ABSTRACT: We have characterized a hematopoietic cell population isolated from murine bone marrow that can facilitate purified hematopoietic stem cell engraftment across fully allogeneic major histocompatibility complex barriers. These facilitating cells (FCs) are classically identified as CD8alpha(+)TCR(-) by flow cytometry. Prior work has demonstrated that FCs are comprised of a heterogeneous cell population with both lymphoid and myeloid phenotypes. The present investigation was designed to more precisely characterize these subsets in terms of both phenotype and developmental potential. Using fluorescence-activated cell sorting analysis, freshly isolated FCs were characterized for phenotypic expression of various lymphocyte progenitor markers. The lymphopoietic potential of FCs was evaluated by culturing freshly isolated FCs on bone marrow stroma cells overexpressing notch ligand 1 (OP9-DL1). Transcripts specific to pTalpha and TCRalpha were quantitated by employing real-time reverse transcription polymerase chain reaction. Maturation of the T-cell receptor (TCR) on FCs was biochemically analyzed by immunoprecipitation. Freshly isolated FCs had significant expression of CD44(+)CD25(-) and CD44(+)CD25(+) phenotypes. A discrete subset of CD8(+)CD4(+) cells are also identified in the FC population, similar to the double-positive phase of thymocyte development. Of particular interest, FCs express pre-TCRalpha (pTalpha) mRNA and protein as demonstrated by reverse transcription polymerase chain reaction, intracellular staining and immunoprecipitation. FCs grown on OP9-DL1 with interleukin-7 and FMS-like tyrosine kinase 3 ligand can mature into CD44(-)CD25(+), CD8(+)CD4(+) and CD8(+) T cells. During this developmental process, expression of the 33-kDa pTalpha chain was replaced by a mature 40-kDa TCRalpha chain. Taken together, these data demonstrate for the first time that the marrow-derived FC contains a T-cell progenitor population that closely resembles developing thymocytes.
    Experimental Hematology 01/2008; 35(12):1847-57. DOI:10.1016/j.exphem.2007.07.016 · 2.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Clinical observations in patients undergoing bone marrow transplantation implicate the involvement of CD8(+) cells in promoting the stem-cell engraftment process. These findings are supported by mouse transplant studies, which attributed the engraftment-facilitating function to subpopulations of murine CD8(+) cells, but the analogous cells in humans have not been identified. Here, we report that clinical stem-cell grafts contain a population of CD8alpha(+)CD3epsilon(+) T-cell receptor- negative cells with an engraftment facilitating function, named candidate facilitating cells (cFCs). Purified cFC augmented human hematopoiesis in NOD/SCID mice receiving suboptimal doses of human CD34(+) cells. In vitro, cFCs cocultured with CD34(+) cells increased hematopoietic colony formation, suggesting a direct effect on clonogenic precursors. These results provide evidence for the existence of rare human CD8(+)CD3(+)TCR(-) cells with engraftment facilitating properties, the adoptive transfer of which could improve the therapeutic outcome of stem-cell transplantation.
    Blood 03/2008; 111(3):1735-8. DOI:10.1182/blood-2007-02-076000 · 10.45 Impact Factor
Show more

Similar Publications